Interpharm Holdings, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IPAH research report →
Price Chart
About the company
Interpharm Holdings, Inc. specializes in the formulation, manufacturing, and commercialization of generic pharmaceuticals, encompassing both prescription-strength and over-the-counter varieties. The company's medicinal products are supplied to a wide array of clients, including significant retail chains, wholesale distributors, managed healthcare organizations, and nationwide distribution networks.
- CEO
- Raj Sutaria
- IPO
- 2000
- Employees
- 670
- HQ
- Hauppauge, NY, US
Get TickerSpark's AI analysis on IPAH
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $660
- P/E
- -0.00
- PEG
- 0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -3.23
- Div Yield
- 0.00%
- Gross Margin
- 28.66%
- Op Margin
- -14.21%
- Net Margin
- -18.60%
- ROE
- -82.09%
- ROIC
- -19.23%
Latest fiscal year · YoY change
- Revenue
- $75.59M+19.3%
- Gross Profit
- $21.67M+24.3%
- Op Income
- $-10,738,000
- Net Income
- $-14,058,000-270.9%
- EPS
- $-0.26-73.3%
- OCF Growth
- -1860.9%
- FCF Growth
- -266.5%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -1.65
- RSI (14)
- 21
- Avg Volume
- 7
No earnings-call transcripts are available for IPAH yet.
- Free Float
- 30.2%
- Shares Outstanding
- 66.04M
- Float Shares
- 19.96M
Our IPAH coverage
Recent articles, reports, and earnings notes.
No research on IPAH yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IPAH report →